The Biotech Investor: How to Profit from the Coming Boom in Biotechnology
Product Description
Condition - Very Good
The item shows wear from consistent use but remains in good condition. It may arrive with damaged packaging or be repackaged.
The Biotech Investor: How to Profit from the Coming Boom in Biotechnology
- Used Book in Good Condition
"Tom Abate's reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner." ―Thom Calandra, editor in chief, CBS MarketWatch
In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry.
Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for
• tracking the effect of breaking news and the NASDAQ
• anticipating drug trial announcements and FDA approvals
• assessing the potential market, patent rights, and distribution deals for a drug
He looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.
Technical Specifications
You might also like
The Biotech Investor's Bible
Cracking the Code: Understand and Profit from the Biotech Revolution That Will Transform Our Lives and Generate Fortunes
The Biotech Trader Handbook (2nd Edition): A Fast, Simplified & Efficient Guide to Potentially Generate Outsized Returns in Biotech Using Options (for the non-scientist)
The BioTech Primer
The Antidote: Inside the World of New Pharma
Biotechnology Demystified
Biotechnology Valuation & Investing: Biotech Valuation & Investing
Genentech: The Beginnings of Biotech (Synthesis)
Science Lessons: What the Business of Biotech Taught Me About Management
The Billion Dollar Molecule: One Company's Quest for the Perfect Drug